|
|
GMDA's EPS from Cont. Operations Growth by Quarter and Year
Gamida Cell Ltd 's EPS from Cont. Operations results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
EPS from Cont. Operations Growth Y/Y▼
|
EPS from Cont. Operations Growth Y/Y▼
|
GMDA EPS from Cont. Operations (in $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
IV Quarter |
December |
-
|
0.30
|
0.00
|
0.00
|
III Quarter |
September |
0.01
|
0.29
|
0.00
|
0.00
|
II Quarter |
June |
0.31
|
0.31
|
0.00
|
0.00
|
I Quarter |
March |
0.27
|
0.34
|
0.00
|
0.00
|
FY |
|
0.59
|
1.24
|
0.00
|
0.00
|
GMDA EPS from Cont. Operations third quarter 2023 Y/Y Growth Comment |
Gamida Cell Ltd reported drop in EPS from Cont. Operations in the third quarter 2023 by -96.55% to $ 0.01 , from the same quarter in 2022. This represents worst decline in recent Company history.
Looking into third quarter 2023 results within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher EPS from Cont. Operations growth. While Gamida Cell Ltd ' s EPS from Cont. Operations meltdown of -96.55% ranks overall at the positon no. 2005 in the third quarter 2023.
|
GMDA EPS from Cont. Operations ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
- |
- |
- |
- |
III Quarter |
September |
-96.55 % |
- |
- |
- |
II Quarter |
June |
0 % |
- |
- |
- |
I Quarter |
March |
-20.59 % |
- |
- |
- |
FY |
|
- |
- |
- |
- |
GMDA EPS from Cont. Operations (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
- |
3.45 % |
- |
- |
III Quarter |
September |
-96.77 % |
-6.45 % |
- |
- |
II Quarter |
June |
14.81 % |
-8.82 % |
- |
- |
I Quarter |
March |
-10 % |
- |
- |
- |
FY (Year on Year) |
|
- |
- |
- |
- |
EPS from Cont. Operations Y/Y Growth Statistics |
High |
Average |
Low |
0 % |
-39.05 % |
-96.55 % |
(Jun 30 2023) |
|
(Sep 30 2023) |
|
EPS from Cont. Operations Y/Y Growth Statistics |
High |
Average |
Low |
0 % |
-39.05 % |
-96.55 % |
(Jun 30 2023) |
|
(Sep 30 2023) |
|
EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Gamida Cell Ltd 's Q/Q EPS from Cont. Operations Growth
EPS from Cont. Operations Q/Q Growth Statistics |
High |
Average |
Low |
14.81 % |
-17.29 % |
-96.77 % |
(Jun 30 2023) |
|
|
GMDA's III. Quarter Q/Q EPS from Cont. Operations Comment |
In the III. Quarter 2023 Gamida Cell Ltd realized fall in EPS from Cont. Operations sequentially by -96.77% to $ 0.01 , from $ 0.31 achived in the previous reporting period.
If you look into present downturn in the III. Quarter 2023, you should take into consideration, that commonly III. Quarter EPS from Cont. Operations occur sluggish then in the preciding period
Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Gamida Cell Ltd 's EPS from Cont. Operations growth quarter on quarter, overall rank is 2086. |
|
|
EPS from Cont. Operations Q/Q Growth Statistics |
High |
Average |
Low |
14.81 % |
-17.29 % |
-96.77 % |
(Jun 30 2023) |
|
|
GMDA's III. Quarter Q/Q EPS from Cont. Operations Comment |
In the III. Quarter 2023 Gamida Cell Ltd realized fall in EPS from Cont. Operations from the previous quarter by -96.77% to $ 0.01 , from $ 0.31 achived in the previous quarter.
It's not big issue, as Gamida Cell Ltd 's EPS from Cont. Operations frequently gravitate to slow in this quarter.
Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Gamida Cell Ltd 's EPS from Cont. Operations growth quarter on quarter, overall rank is 2086. |
|
Gamida Cell Ltd 's 12 Months EPS from Cont. Operations Growth Year on Year
EPS from Cont. Operations TTM Growth |
12 Months Ending (Sep 30 2023) |
12 Months Ending (Jun 30 2023) |
12 Months Ending (Mar 31 2023) |
12 Months Ending (Dec 31 2022) |
12 Months Ending (Sep 30 2022) |
Cumulative EPS from Cont. Operations 12 Months Ending |
$ 0.89 |
$ 1.17 |
$ 1.17 |
$ 1.24 |
$ 0.00 |
Y / Y EPS from Cont. Operations Growth (TTM) |
- |
- |
- |
- |
- |
Year on Year EPS from Cont. Operations Growth Overall
Ranking |
# |
# |
# |
# |
# |
Seqeuential EPS from Cont. Operations Change (TTM) |
-23.92 % |
0 % |
-5.64 % |
- |
- |
Seq. EPS from Cont. Operations Growth (TTM) Overall
Ranking |
# |
| | |